about
Effectiveness of non-nucleoside reverse-transcriptase inhibitor-based antiretroviral therapy in women previously exposed to a single intrapartum dose of nevirapine: a multi-country, prospective cohort studyTotal HIV/AIDS expenditures in Dehong Prefecture, Yunnan province in 2010: the first systematic evaluation of both health and non-health related HIV/AIDS expenditures in ChinaEstimating the size of HIV key affected populations in Chongqing, China, using the network scale-up methodPreliminary Report on HIV-1 Vaccine Preparedness in Nigeria: Advantages of Recruiting University StudentsContributions of international cooperation projects to the HIV/AIDS response in China.Estimation of HIV-1 incidence among five focal populations in Dehong, Yunnan: a hard hit area along a major drug trafficking routePredictors of virologic failure in HIV-1-infected adults receiving first-line antiretroviral therapy in 8 provinces in ChinaHIV-infected former plasma donors in rural Central China: from infection to survival outcomes, 1985-2008.Role of traditional birth attendants in preventing perinatal transmission of HIV.Triple-antiretroviral prophylaxis to prevent mother-to-child HIV transmission through breastfeeding--the Kisumu Breastfeeding Study, Kenya: a clinical trial.Improving health services for African migrants in China: A health diplomacy perspective.Hepatitis B and hepatitis C seroprevalence in children receiving antiretroviral therapy for human immunodeficiency virus-1 infection in China, 2005-2009.Evaluation of rapid prenatal human immunodeficiency virus testing in rural cameroon.Antiretroviral therapy during pregnancy and the risk of an adverse outcome.Family experiences with pediatric antiretroviral therapy: responsibilities, barriers, and strategies for remembering medicationsAssessing medication adherence of perinatally HIV-infected children using caregiver interviews.Design and implementation of a China comprehensive AIDS response programme (China CARES), 2003-08.Safety of tenofovir during pregnancy for the mother and fetus: a systematic review.Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes.The integration of multiple HIV/AIDS projects into a coordinated national programme in China.Early childhood infection by human herpesvirus 8 in Zambia and the role of human immunodeficiency virus type 1 coinfection in a highly endemic areaRapid intrapartum or postpartum HIV testing at a midwife obstetric unit and a district hospital in South Africa.Five-year outcomes of the China National Free Antiretroviral Treatment Program.A cluster-randomized trial of enhanced labor ward-based PMTCT services to increase nevirapine coverage in Lusaka, Zambia.Placental malaria and mother-to-child transmission of human immunodeficiency virus-1 in rural Rwanda.Cotrimoxazole prophylaxis and antiretroviral therapy: an observational cohort study in China.Mortality trends in the US Perinatal AIDS Collaborative Transmission Study (1986-2004)HIV-HBV coinfection--a global challengeUltrasensitive p24 antigen assay for diagnosis of perinatal human immunodeficiency virus type 1 infection.Improved survival with co-trimoxazole prophylaxis among people living with HIV/AIDS who initiated antiretroviral treatment in Henan Province, China.Prevalence of HIV among women entering labor who accepted or declined voluntary counseling and testingMother-to-child transmission of HIV-1: timing and implications for prevention.Human resource development and capacity-building during China's rapid scale-up of methadone maintenance treatment services.Care and treatment of HIV-infected children in Africa: issues and challenges at the district hospital level.Evaluation of PIMA point-of-care CD4 analyzer in Yunnan, China.Approaches for scaling up human immunodeficiency virus testing and counseling in prevention of mother-to-child human immunodeficiency virus transmission settings in resource-limited countries.HIV and syphilis prevalence among men who have sex with men: a cross-sectional survey of 61 cities in China.Effects of early, abrupt weaning on HIV-free survival of children in Zambia.Factors associated with mortality of HIV-positive clients receiving methadone maintenance treatment in China.Is the HIV sentinel surveillance system adequate in China? Findings from an evaluation of the national HIV sentinel surveillance system.
P50
Q28472889-BDAC57AC-4A62-41B9-8843-0033C2F5A923Q28534308-31E413CA-09EE-4C83-9AD3-BAB07F10CE4DQ28535283-B88F895D-1776-491B-97E3-F7899A27E3A0Q30227364-1CF577DB-1769-4713-BA3B-C11C13400C6AQ30396570-D7963DF2-09D7-4EAD-B5C5-137C13B32E3BQ33550575-1B4534A6-740B-4A77-8DCE-A7DABE2CCA9BQ33586369-F8170E3B-24E7-4DE4-BCBD-952BB3A19C14Q33742029-FA996E52-087C-4F6A-B70A-B212CFB72666Q33808843-3E0D7AC3-339B-4C3C-BD6E-782D3751A220Q33863552-44CBF2DE-CAB9-4343-BD76-F4F1347B4F20Q33873818-3626EDEF-B6FA-4D41-B8D4-12B3FDC5EAE5Q33882122-CBF6697C-8072-4691-BD4B-9FB18F23F9ACQ33910826-AF8B8DB5-FCE3-40E1-8375-CF33DEDA4DB0Q33959672-1A2A26E4-CFE7-4C7C-991F-B5F624DC2460Q34087770-4834ADAC-7252-4FAF-A075-054FFF736993Q34242255-0667799E-2A9A-4484-A98F-CE795B746110Q34354317-0FCBC5A2-1A0E-443B-B6BC-541378B9FC1DQ34371989-65868B73-2724-4508-8491-CD17140991D4Q34556854-E17DC985-132E-446D-AE69-057896FBF4A0Q34601727-DE68D123-3267-445E-90D1-F2061F751DA0Q34783313-44BAA8B3-2C5F-44A9-BBFE-FF73240597D5Q34925139-67453AF5-0365-498A-B5FE-C39896A3B769Q34997946-BAD6FB7A-CF50-4349-A9EE-A1036738CCC8Q35013809-7A33EBA8-EAEB-424C-9913-6F9D75E1824CQ35131348-7B45535D-888E-4385-A7B5-1709777BA970Q35211308-F8D7BE5B-EC72-46B8-817C-82E2EBF9BBF2Q35452217-B02B3F97-498B-46B1-8D67-D66B1E72E208Q35678473-770EFD86-A280-4F7E-A80D-5372A88D2A48Q35913802-25D40F3F-541C-4489-AD78-E3F793DE2BA6Q36480371-B1972057-4348-4737-AAAA-56D201CA0A99Q36557167-730C1A71-A14F-4C2D-A592-5E48C464F117Q36635880-D9204586-F7D0-4380-908C-9562C48C8315Q36706991-EE905C49-7A95-4482-88B9-FDFBB0FFBBA6Q36720836-307803F4-BFFB-4B72-B34D-215C2B0D4D85Q36804868-234BA5CD-7ABF-412F-AA18-5EFE92FD8537Q36934074-381765E3-2E16-4299-9D6A-DAFFFBAA3F6EQ36946251-11D5C571-101B-41AC-8A8B-8C99DE7A3AEDQ36960424-D3BDE61A-4B10-46EA-B99D-6266096AB84BQ36974887-F6003EDC-F775-4759-AF9B-568CAA570CCBQ37059113-004D98A8-5258-4104-9338-546ED1EE420B
P50
description
researcher
@en
name
Marc Bulterys
@en
type
label
Marc Bulterys
@en
prefLabel
Marc Bulterys
@en
P31
P496
0000-0002-9157-3431